Allarity Therapeutics ALLR
NASDAQ ALLR
$1.04 +0.08 (+8.24%)
As of: Sep 30, 2026 · 12:11 PM EDT

Allarity Therapeutics (ALLR) EBT Margin (2026)

Updated

Allarity Therapeutics (ALLR) posted EBT Margin of -11016.00% for Q1 2026.

Analysis

Allarity Therapeutics (ALLR) EBT Margin (2026) Analysis & Trends

For FY2025, Allarity Therapeutics' EBT Margin came in at -3509.69%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Allarity Therapeutics 1.56 Mn 1.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,016.00%
API Access

Allarity Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALLR&period=max&api_key=YOUR_API_KEY